Skip to main content
. 2015 Feb 1;8(2):1705–1711.

Figure 1.

Figure 1

Expression levels of miR-365 and clinicopathological characteristics in HCC. A. Comparison of miR-365 expression levels between HCC tissues and adjacent normal tissues. B. The expression level of miR-365 in HCC patients at different clinical stages. C. The expression level of miR-365 at different differentiation of HCC tissues. D. Overall survival curve of HCC patients with different miR-365 expression. The patients with a lower expression of miR-365 had a lower survival time compared with those with a higher expression of miR-365. (*P < 0.05).